Analysis showed elevated CCL2 serum levels in the early AMD group compared to control subjects (median (IQR): 1181.6 (522.6) pg/mL vs. 879.9 (494.4) pg/mL, p = 0.013) (Figure 2). This evidence concerns the gene CCL2 and age-related macular degeneration.